No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
244 (estimated)
Sponsor
VA Office of Research and Development · Federal
Who this trial is looking for
This trial is looking for veterans who have had a right brain stroke and have difficulties with daily activities. Participants will undergo special training with prisms to help improve their ability to function.
Are You a Good Fit for This Trial?
You may be able to join if
I have had a first right brain stroke
I am between 1 and 4 months post-stroke
I can sit up and see out of both eyes
I can point to objects
I can give informed consent
You may not be able to join if
I have another serious neurological disorder
I have had a left brain stroke
I cannot sit up to be tested
I have poor vision in both eyes
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
After a right brain stroke, \>50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and their needs in the hospital and at home are greatly increased. An effective treatment for spatial neglec…
After a right brain stroke, \>50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and their needs in the hospital and at home are greatly increased. An effective treatment for spatial neglect is 10 days of visuomotor training while wearing optical prisms (PAT), however many clinicians \[fail to diagnose spatial neglect and use this approach. In this study, the investigators will develop a brain scanning test that could objectively identify the Veterans with spatial neglect after stroke who are the best candidates to receive PAT and recover their ability to function. When the research is complete, the investigators expect that brain scans done in the hospital can guide the team to refer Veterans to PAT rehabilitation: improving daily life function\] and quality of life.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Has had a first right brain stroke \>18 years of age
* 1-4 months post-diagnosis of right brain stroke
* Can sit up, see out of both eyes and point to objects (\>20/50 vision in both eyes)
* Can give informed consent to participate
Exclusion Criteria:
* Has been diagnosed wi…
Inclusion Criteria:
* Has had a first right brain stroke \>18 years of age
* 1-4 months post-diagnosis of right brain stroke
* Can sit up, see out of both eyes and point to objects (\>20/50 vision in both eyes)
* Can give informed consent to participate
Exclusion Criteria:
* Has been diagnosed with other chronic, disabling neurological disorder (e.g. multiple sclerosis, Alzheimer Disease)
* Has had a clinical left brain stroke or has neuroimaging evidence of prior stroke(s) including the presence of more than two lacunes with diameter greater than 15 mm.
* Cannot sit up to be tested and receive PAT
* Has \<20/50 vision when viewing with both eyes
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.